IER5 and Alzheimer disease: IER5 is an established regulator of molecular chaperone expression, and has been reported to mediate upregulation of chaperone proteins upon sleep deprivation [89], suggesting a link between proteostasis and sleep, both of which are disrupted in AD, and both of which promote tauopathy [90–93].